
S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON‐ELIGIBLE PATIENTS WITH NDMM (AGMT‐MM02 TRIAL)
Author(s) -
Ludwig H.,
Melchardt T.,
Sormann S.,
Zojer N.,
Andel J.,
Hartmann B.,
Tinchon C.,
Gunsilius E.,
Podar K.,
Egle A.,
Willenbacher W.,
Wöll E.,
Schreder M.,
Ruckser R.,
Bozic B,
Krauth M.T.,
Petzer A.,
Schmitt C,
MachherndlSpandl S.,
Agis H.,
Fillitz M.,
Pönisch W.,
Knop S.,
Paiva B.,
Greil R.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843608.22124.95
Subject(s) - medicine , carfilzomib , thalidomide , population , lenalidomide , randomized controlled trial , dexamethasone , multiple myeloma , transplantation , surgery , environmental health